Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00146146Phase 3Completed
Phase 3, randomised, open-label trial of testosterone undecanoate in gender dysphoria (GD), sponsored by Unità Operativa Complessa di Ostetricia e Ginecologia. Started May 2005; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00146146.